Kirin Health Science Australia Pty Ltd entered into a scheme implementation deed to acquire Blackmores Limited (ASX:BKL) from AustralianSuper Pty Ltd., FIL Limited, Marcus Charles Blackmore and others for AUD 1.9 billion on April 26, 2023. As per the transaction, Kirin Holdings Company, Limited will pay AUD 95 per share to the shareholders of Blackmores Limited as consideration. Kroll, LLC, Blackmore's fairness opinion provider has opined that the offer is fair and reasonable. The Transaction will be funded through available cash and existing debt facilities. The transaction is subject to approval by Independent Expert, informal clearance by the Australian Competition and Consumer Commission, approval of the Foreign Investment Review Board, approval of the State Administration for Market Regulation (SAMR) of the People?s Republic of China approval of Blackmores shareholders and the Federal Court of Australia and is approved by board of directors of Blackmores Limited. A Blackmores shareholder meeting will be convened on July 18, 2023, in order to approve the scheme. Marcus Blackmore, whose father founded the company, has entered into an agreement with Kirin to vote all his shares in favour of the scheme. The transaction is expected to close in early August. Normalized EPS is expected to be accretive from the first year. As of May 2, 2023. As of July 3, 2023, the transaction is approved by Foreign Investment Review Board and State Administration for Market Regulation. The deal, expected to be closed around August or September. As of July 18, 2023, target shareholders approved the transaction. Barrenjoey Capital Partners and Adara Partners acted as financial advisors and Rebecca Maslen-Stannage, James Shirbin, Danielle Farrell of Herbert Smith Freehills acted as legal advisor to Blackmores Limited. Perth Partners Scott Gibson and Michael Ng of Thomson Geer team acted as legal advisor to Kirin. Blackmores Registry Computershare Investor Services Pty Limited acted as registrar to Blackmores Limited. Kroll, LLC acted as a fairness opinion provider to Blackmores. Deloitte Touche Tohmatsu LLC and Ernst & Young Australia acted as accountant to Blackmores.

Kirin Health Science Australia Pty Ltd completed the acquisition of Blackmores Limited (ASX:BKL) from AustralianSuper Pty Ltd., FIL Limited, Marcus Charles Blackmore and others on August 10, 2023. Kirin Health Science scheduled public issuance of domestic Social Bonds ("Issuance") of JPY 90 billion (AUD 0.94857 billion) to raise funds for the acquisition of shares in Blackmores Limited.